Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Bryan Haugen

Concepts (516)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thyroid Neoplasms
101
2026
350
16.610
 Why?
Adenocarcinoma, Follicular
20
2026
40
3.670
 Why?
Iodine Radioisotopes
29
2025
136
3.600
 Why?
Thyroid Nodule
18
2025
57
3.510
 Why?
Carcinoma, Papillary
24
2017
77
3.270
 Why?
Thyroid Gland
26
2018
89
3.140
 Why?
Endocrinology
10
2020
77
2.900
 Why?
Thyrotropin
30
2023
120
2.580
 Why?
Carcinoma
10
2025
224
1.740
 Why?
Thyroid Diseases
9
2026
44
1.610
 Why?
Thyroidectomy
17
2024
92
1.330
 Why?
Retinoid X Receptors
11
2011
38
1.210
 Why?
Antineoplastic Agents
15
2022
2207
1.190
 Why?
Retinoids
7
2011
33
1.140
 Why?
Hypothyroidism
8
2023
67
1.110
 Why?
Tetrahydronaphthalenes
6
2015
31
1.110
 Why?
Thyroid Carcinoma, Anaplastic
6
2019
36
1.100
 Why?
Carcinoma, Neuroendocrine
2
2025
36
1.020
 Why?
Thyroxine
12
2023
65
1.010
 Why?
Biomarkers, Tumor
15
2024
1320
0.980
 Why?
Receptors, Retinoic Acid
7
2004
42
0.970
 Why?
Biopsy, Fine-Needle
9
2021
68
0.900
 Why?
Carcinoma, Medullary
2
2025
16
0.900
 Why?
NF-kappa B
3
2015
664
0.900
 Why?
Ultrasonography
9
2026
784
0.870
 Why?
Lymphatic Metastasis
7
2024
331
0.850
 Why?
Carcinoma, Papillary, Follicular
4
2014
8
0.840
 Why?
Thyroglobulin
9
2026
29
0.820
 Why?
Neoplasm Proteins
6
2013
441
0.800
 Why?
Transcription Factors
15
2014
1731
0.780
 Why?
Gene Expression Profiling
6
2020
1763
0.770
 Why?
Cell Line, Tumor
20
2023
3539
0.760
 Why?
Humans
142
2026
145140
0.760
 Why?
Struma Ovarii
2
2014
8
0.720
 Why?
Radiopharmaceuticals
3
2012
205
0.710
 Why?
Proto-Oncogene Proteins B-raf
3
2023
223
0.660
 Why?
Thiazolidinediones
4
2018
139
0.650
 Why?
Neoplasm Invasiveness
6
2017
506
0.650
 Why?
Pituitary Gland
6
2011
149
0.640
 Why?
Promoter Regions, Genetic
14
2018
1244
0.640
 Why?
Thyroid Hormones
5
2023
68
0.630
 Why?
History, 20th Century
7
2018
327
0.620
 Why?
Oncogene Proteins, Fusion
2
2019
212
0.620
 Why?
Lymph Nodes
5
2018
502
0.590
 Why?
Cell Differentiation
5
2020
2040
0.580
 Why?
Triiodothyronine
4
2017
54
0.560
 Why?
T-Lymphocytes, Regulatory
3
2015
407
0.550
 Why?
Neoplasm Metastasis
10
2015
688
0.550
 Why?
History, 21st Century
6
2018
220
0.540
 Why?
Neoplasm Recurrence, Local
8
2024
1146
0.530
 Why?
Proto-Oncogene Proteins p21(ras)
1
2019
254
0.530
 Why?
Hypothalamus
2
2011
163
0.530
 Why?
Recombinant Proteins
9
2009
1368
0.510
 Why?
Mutation
11
2023
4071
0.500
 Why?
Programmed Cell Death 1 Receptor
3
2016
264
0.500
 Why?
Societies, Medical
6
2020
898
0.490
 Why?
Neoplasm Staging
14
2021
1467
0.480
 Why?
Multimodal Imaging
2
2014
129
0.480
 Why?
Molecular Targeted Therapy
3
2015
438
0.470
 Why?
Drug Resistance, Neoplasm
4
2023
881
0.470
 Why?
Pharmacogenomic Testing
1
2016
63
0.470
 Why?
Ovarian Neoplasms
2
2014
594
0.460
 Why?
Protein-Tyrosine Kinases
1
2019
431
0.460
 Why?
DNA-Binding Proteins
13
2014
1479
0.450
 Why?
Transcriptome
3
2020
1029
0.450
 Why?
Databases, Genetic
1
2016
238
0.440
 Why?
Famous Persons
1
2014
7
0.430
 Why?
Terminology as Topic
1
2017
256
0.430
 Why?
Anticarcinogenic Agents
1
2015
62
0.430
 Why?
Tomography, Emission-Computed, Single-Photon
2
2014
104
0.420
 Why?
Physician Executives
1
2014
30
0.420
 Why?
Data Collection
3
2016
639
0.420
 Why?
Reverse Transcriptase Polymerase Chain Reaction
9
2014
977
0.420
 Why?
Hyperthyroidism
2
2012
22
0.410
 Why?
Mice
29
2023
18303
0.410
 Why?
Gene Expression Regulation, Neoplastic
7
2018
1442
0.410
 Why?
Immunotherapy, Adoptive
1
2017
342
0.410
 Why?
Neoplasm Transplantation
5
2019
246
0.400
 Why?
Genes, Tumor Suppressor
1
2014
85
0.400
 Why?
Gene Expression
2
2012
1474
0.400
 Why?
Combined Modality Therapy
8
2021
1264
0.390
 Why?
Interleukin-8
1
2014
269
0.380
 Why?
Antineoplastic Combined Chemotherapy Protocols
5
2024
1958
0.380
 Why?
Cell Proliferation
10
2023
2504
0.380
 Why?
Medical Oncology
1
2016
338
0.370
 Why?
Middle Aged
38
2026
36126
0.370
 Why?
Phenylurea Compounds
2
2024
119
0.370
 Why?
Research
1
2016
430
0.370
 Why?
Neovascularization, Pathologic
1
2014
285
0.370
 Why?
Proteomics
3
2010
1185
0.360
 Why?
Pituitary Gland, Anterior
4
2002
37
0.350
 Why?
Female
55
2026
78636
0.350
 Why?
Radiotherapy, Adjuvant
2
2012
221
0.350
 Why?
Quinolines
2
2024
190
0.350
 Why?
RNA, Messenger
15
2012
2803
0.350
 Why?
Antigens, Neoplasm
2
2026
271
0.350
 Why?
Animals
33
2023
37952
0.340
 Why?
T-Lymphocytes
3
2026
1993
0.340
 Why?
Bone Neoplasms
2
2012
255
0.330
 Why?
Practice Guidelines as Topic
5
2020
1579
0.330
 Why?
Decision Support Techniques
1
2015
472
0.330
 Why?
Telomerase
5
2019
246
0.330
 Why?
Aged
27
2026
26096
0.330
 Why?
Lymphocytes, Tumor-Infiltrating
2
2026
153
0.320
 Why?
DNA, Neoplasm
2
2008
158
0.320
 Why?
Protein Kinase Inhibitors
3
2024
979
0.320
 Why?
Blotting, Western
8
2014
1177
0.320
 Why?
Male
48
2026
72664
0.320
 Why?
PPAR gamma
3
2009
178
0.320
 Why?
Prognosis
12
2024
4310
0.310
 Why?
Carrier Proteins
1
2014
728
0.310
 Why?
MAP Kinase Kinase 2
1
2009
28
0.300
 Why?
MAP Kinase Kinase 1
1
2009
70
0.290
 Why?
Proto-Oncogene Proteins pp60(c-src)
1
2009
14
0.290
 Why?
Focal Adhesion Protein-Tyrosine Kinases
1
2009
35
0.290
 Why?
Cell Culture Techniques
2
2009
372
0.290
 Why?
Forkhead Transcription Factors
1
2010
207
0.290
 Why?
Adult
36
2026
40665
0.280
 Why?
Signal Transduction
6
2023
5208
0.270
 Why?
Iodide Peroxidase
2
2005
35
0.270
 Why?
Hormone Replacement Therapy
2
2020
107
0.270
 Why?
Receptors, Cytoplasmic and Nuclear
2
2009
207
0.270
 Why?
Treatment Outcome
18
2024
11741
0.260
 Why?
Quinazolines
1
2009
266
0.260
 Why?
MAP Kinase Signaling System
1
2009
307
0.260
 Why?
Cell Transformation, Neoplastic
2
2012
337
0.260
 Why?
Benzodioxoles
1
2009
161
0.250
 Why?
Adenoma
3
2025
218
0.250
 Why?
S100 Proteins
1
2006
35
0.240
 Why?
Adenoma, Oxyphilic
2
2024
7
0.240
 Why?
Diagnosis, Differential
6
2025
1506
0.240
 Why?
Apoptosis
4
2012
2434
0.240
 Why?
Disease-Free Survival
5
2021
766
0.240
 Why?
Lipoprotein Lipase
2
2004
56
0.240
 Why?
Evidence-Based Medicine
3
2020
739
0.240
 Why?
Genetic Heterogeneity
1
2026
65
0.230
 Why?
Retrospective Studies
12
2025
17247
0.230
 Why?
Polymorphism, Single Nucleotide
3
2026
2136
0.230
 Why?
Tamoxifen
3
2023
191
0.230
 Why?
Molecular Diagnostic Techniques
2
2021
103
0.230
 Why?
Multiple Endocrine Neoplasia Type 2a
1
2025
14
0.230
 Why?
Hamartoma Syndrome, Multiple
1
2025
16
0.230
 Why?
Adenomatous Polyposis Coli
1
2025
40
0.230
 Why?
Oligonucleotide Array Sequence Analysis
3
2014
749
0.220
 Why?
Mice, Nude
5
2018
679
0.220
 Why?
Melanoma
2
2009
759
0.220
 Why?
Tomography, X-Ray Computed
3
2018
2767
0.220
 Why?
Tumor Cells, Cultured
8
2009
886
0.220
 Why?
Goiter, Nodular
1
2004
2
0.210
 Why?
Retinoid X Receptor gamma
1
2004
4
0.210
 Why?
Neoplasms
3
2016
2900
0.210
 Why?
Galectin 3
1
2004
21
0.210
 Why?
United States
14
2025
16065
0.210
 Why?
Chromosomal Proteins, Non-Histone
2
2002
130
0.210
 Why?
Sensitivity and Specificity
6
2024
1995
0.210
 Why?
Dietary Fats
2
2004
308
0.210
 Why?
Immunohistochemistry
7
2020
1713
0.210
 Why?
Microtubule-Associated Proteins
2
2002
194
0.210
 Why?
Molecular Sequence Data
13
2006
2881
0.200
 Why?
Radionuclide Imaging
4
2010
115
0.200
 Why?
Cell Cycle
2
2023
596
0.200
 Why?
Cell Line
4
2022
2821
0.200
 Why?
Drug Resistance
2
2022
145
0.200
 Why?
Whole-Body Counting
2
2006
7
0.190
 Why?
Genome-Wide Association Study
2
2026
1376
0.180
 Why?
Prospective Studies
12
2023
8035
0.180
 Why?
Cell Cycle Proteins
1
2006
629
0.180
 Why?
Benzoates
3
2009
49
0.180
 Why?
Estrogen Receptor alpha
1
2023
151
0.180
 Why?
Aged, 80 and over
10
2024
8318
0.170
 Why?
Disease Models, Animal
4
2022
4552
0.170
 Why?
Cytodiagnosis
1
2021
31
0.170
 Why?
Reoperation
1
2024
630
0.170
 Why?
Consensus
3
2020
478
0.160
 Why?
Artificial Intelligence
1
2026
381
0.160
 Why?
Genetic Predisposition to Disease
2
2026
2351
0.160
 Why?
Thyroid Hormone Resistance Syndrome
1
2000
1
0.160
 Why?
Base Sequence
11
2002
2168
0.160
 Why?
Estrogens
1
2023
367
0.160
 Why?
Xenograft Model Antitumor Assays
4
2020
932
0.160
 Why?
Lymphoma
1
2002
233
0.160
 Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
3
2010
142
0.150
 Why?
Breast Neoplasms
3
2023
2380
0.150
 Why?
CD8-Positive T-Lymphocytes
3
2016
917
0.150
 Why?
Adenocarcinoma
3
2017
920
0.150
 Why?
Vascular Endothelial Growth Factor A
1
2022
552
0.140
 Why?
Transfection
5
2005
926
0.140
 Why?
Nitriles
2
2010
207
0.140
 Why?
Antibodies, Monoclonal, Humanized
1
2024
992
0.140
 Why?
Thyrotropin, beta Subunit
2
2011
5
0.130
 Why?
Receptors, Estrogen
1
2020
401
0.130
 Why?
Up-Regulation
1
2020
846
0.130
 Why?
Intercellular Adhesion Molecule-1
1
2017
132
0.130
 Why?
Neck
2
2015
108
0.130
 Why?
Tissue Extracts
1
2017
19
0.130
 Why?
Workflow
1
2018
183
0.130
 Why?
Algorithms
5
2018
1845
0.130
 Why?
Heterografts
2
2015
143
0.130
 Why?
Disease Progression
6
2020
2857
0.120
 Why?
Transcription Factor Pit-1
8
1999
26
0.120
 Why?
Parathyroidectomy
1
2016
9
0.120
 Why?
Enzyme Inhibitors
2
2010
820
0.120
 Why?
Tretinoin
1
1997
125
0.120
 Why?
Muscle, Skeletal
2
2004
1789
0.120
 Why?
Colorado
3
2014
4538
0.120
 Why?
Ligands
3
2009
664
0.120
 Why?
Prolactin
2
1999
87
0.110
 Why?
Homeodomain Proteins
3
1999
522
0.110
 Why?
Caspase 7
1
2015
22
0.110
 Why?
Larynx
1
2016
56
0.110
 Why?
Diet
1
2023
1277
0.110
 Why?
Bortezomib
1
2015
54
0.110
 Why?
Inhibitory Concentration 50
1
2015
90
0.110
 Why?
Information Storage and Retrieval
1
2016
123
0.110
 Why?
User-Computer Interface
1
2016
165
0.110
 Why?
Hypocalcemia
1
2015
39
0.110
 Why?
Taxoids
1
2015
114
0.110
 Why?
Radiation, Ionizing
1
2015
86
0.110
 Why?
Pharmacogenetics
1
2016
174
0.110
 Why?
Transcriptional Activation
2
1994
372
0.110
 Why?
Laryngoscopy
1
2016
119
0.110
 Why?
Tumor Suppressor Protein p53
1
2019
532
0.110
 Why?
Double-Blind Method
2
2012
2057
0.110
 Why?
Immunophenotyping
2
2015
318
0.110
 Why?
Risk Assessment
4
2024
3740
0.110
 Why?
Guidelines as Topic
1
2016
266
0.110
 Why?
Caspase 3
1
2015
242
0.110
 Why?
Societies, Scientific
1
2014
50
0.110
 Why?
Growth Hormone
1
1994
91
0.110
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2017
261
0.100
 Why?
NF-KappaB Inhibitor alpha
1
2014
50
0.100
 Why?
DNA Mutational Analysis
2
2020
407
0.100
 Why?
Immunotherapy
2
2016
665
0.100
 Why?
Histiocytoma, Benign Fibrous
1
1994
7
0.100
 Why?
Energy Metabolism
1
2000
933
0.100
 Why?
Predictive Value of Tests
2
2019
2115
0.100
 Why?
Diagnostic Techniques, Endocrine
1
2013
14
0.100
 Why?
Graves Disease
2
2012
32
0.100
 Why?
I-kappa B Proteins
1
2014
75
0.100
 Why?
Cell Death
1
2015
382
0.100
 Why?
Transduction, Genetic
1
2014
132
0.100
 Why?
Stilbenes
1
2013
30
0.100
 Why?
Human Umbilical Vein Endothelial Cells
1
2014
104
0.100
 Why?
ROC Curve
1
2015
617
0.100
 Why?
Drug Resistance, Multiple
1
2013
25
0.100
 Why?
Preoperative Care
3
2024
380
0.100
 Why?
Transcription, Genetic
5
2011
1454
0.100
 Why?
Young Adult
6
2024
14176
0.090
 Why?
Genetic Variation
1
2018
967
0.090
 Why?
Observer Variation
1
2013
356
0.090
 Why?
Sirolimus
1
2014
280
0.090
 Why?
Registries
6
2015
2401
0.090
 Why?
Contraindications
1
2012
90
0.090
 Why?
T-Lymphocyte Subsets
2
2015
417
0.090
 Why?
Nuclear Proteins
1
1997
738
0.090
 Why?
Receptors, Thyroid Hormone
3
1996
18
0.090
 Why?
src-Family Kinases
1
2012
92
0.090
 Why?
Protein Isoforms
2
2004
396
0.090
 Why?
Thiazoles
1
2012
140
0.090
 Why?
Thyroiditis, Autoimmune
2
2020
16
0.090
 Why?
Glycoprotein Hormones, alpha Subunit
1
2011
23
0.080
 Why?
Mice, 129 Strain
1
2011
84
0.080
 Why?
Genomics
1
2016
819
0.080
 Why?
TOR Serine-Threonine Kinases
1
2014
454
0.080
 Why?
Oleanolic Acid
1
2010
9
0.080
 Why?
Adolescent
7
2024
22479
0.080
 Why?
Cells, Cultured
3
2014
4142
0.080
 Why?
Polymerase Chain Reaction
4
2005
1039
0.080
 Why?
Whole Body Imaging
1
2010
29
0.080
 Why?
Amino Acid Sequence
4
2006
2127
0.080
 Why?
Ribonucleases
3
2002
48
0.080
 Why?
Electrophoresis, Gel, Two-Dimensional
2
2008
110
0.080
 Why?
Lymphocyte Subsets
1
2010
77
0.080
 Why?
Weight Gain
2
2023
561
0.080
 Why?
Antibody Specificity
1
2010
177
0.080
 Why?
Somatostatin
1
2009
53
0.080
 Why?
Quality Improvement
1
2018
1293
0.080
 Why?
Dopamine Agonists
1
2009
41
0.080
 Why?
Lymphoma, T-Cell
1
2009
29
0.080
 Why?
Pilot Projects
1
2015
1889
0.080
 Why?
Butadienes
1
2009
33
0.080
 Why?
Diphosphonates
1
2010
68
0.070
 Why?
Sulfones
1
2010
127
0.070
 Why?
Endometrial Neoplasms
2
2002
205
0.070
 Why?
Calcium
1
2015
1189
0.070
 Why?
Bone Density Conservation Agents
1
2010
81
0.070
 Why?
Hysterectomy
1
2010
138
0.070
 Why?
Radiotherapy
1
2010
204
0.070
 Why?
Drug Screening Assays, Antitumor
1
2009
194
0.070
 Why?
Phosphorylation
2
2012
1706
0.070
 Why?
Benzamides
1
2009
224
0.070
 Why?
Pyrimidines
1
2012
530
0.070
 Why?
Membrane Proteins
1
2015
1163
0.070
 Why?
Time Factors
3
2010
7107
0.070
 Why?
Drug Evaluation, Preclinical
1
2009
196
0.070
 Why?
Flow Cytometry
1
2012
1159
0.070
 Why?
Lymphocyte Activation
1
2012
1131
0.070
 Why?
Postoperative Complications
2
2023
2961
0.070
 Why?
CD4-Positive T-Lymphocytes
2
2015
1138
0.070
 Why?
Enzyme Activation
1
2009
762
0.060
 Why?
Cohort Studies
5
2023
5988
0.060
 Why?
Autoantibodies
2
2013
1508
0.060
 Why?
Proportional Hazards Models
3
2023
1325
0.060
 Why?
Phenotype
3
2015
3138
0.060
 Why?
S100 Calcium Binding Protein A6
1
2006
1
0.060
 Why?
RNA, Small Interfering
1
2009
634
0.060
 Why?
Follow-Up Studies
5
2024
5411
0.060
 Why?
Reproducibility of Results
2
2019
3410
0.060
 Why?
Colonic Neoplasms
1
2008
257
0.060
 Why?
Fatty Acids, Nonesterified
1
2006
154
0.060
 Why?
Metformin
1
2009
327
0.060
 Why?
Pituitary Neoplasms
2
1999
190
0.060
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2006
105
0.060
 Why?
Proto-Oncogene Proteins c-ret
1
2025
41
0.060
 Why?
Neoplasm Grading
2
2018
310
0.060
 Why?
Chromatin Immunoprecipitation
1
2005
139
0.060
 Why?
Drug Delivery Systems
1
2009
380
0.060
 Why?
Inhibitor of Apoptosis Proteins
2
2002
46
0.060
 Why?
Glucocorticoids
1
2009
531
0.060
 Why?
Postoperative Care
2
2018
286
0.060
 Why?
RNA, Neoplasm
2
2002
83
0.060
 Why?
Blotting, Southern
2
1996
84
0.050
 Why?
Neck Dissection
1
2024
17
0.050
 Why?
Chromosome Mapping
2
1997
504
0.050
 Why?
Paclitaxel
1
2006
256
0.050
 Why?
Brain Neoplasms
1
2014
1328
0.050
 Why?
Recurrent Laryngeal Nerve Injuries
1
2024
16
0.050
 Why?
Organic Chemicals
1
2005
111
0.050
 Why?
Adjuvants, Pharmaceutic
1
2004
15
0.050
 Why?
United Kingdom
1
2025
336
0.050
 Why?
Tomography, Emission-Computed
1
2004
71
0.050
 Why?
PTEN Phosphohydrolase
1
2025
165
0.050
 Why?
Triglycerides
1
2006
520
0.050
 Why?
Luciferases
1
2004
152
0.050
 Why?
Immunoprecipitation
1
2004
148
0.050
 Why?
DNA, Mitochondrial
1
2005
211
0.050
 Why?
Heart Neoplasms
2
2015
56
0.050
 Why?
Probability
2
2021
307
0.050
 Why?
Cell Cycle Checkpoints
2
2016
97
0.050
 Why?
Dose-Response Relationship, Drug
2
2005
2026
0.050
 Why?
Professional Practice
1
2003
57
0.050
 Why?
Lymph Node Excision
1
2024
173
0.050
 Why?
Quality of Life
3
2022
3194
0.050
 Why?
Computers
1
2023
66
0.050
 Why?
National Institutes of Health (U.S.)
1
2023
147
0.050
 Why?
Protein Binding
1
2009
2235
0.050
 Why?
Genetic Testing
2
2018
480
0.050
 Why?
Poly A
1
2002
50
0.050
 Why?
5' Untranslated Regions
1
2002
59
0.050
 Why?
Cell Division
1
2004
753
0.040
 Why?
Gene Library
1
2002
122
0.040
 Why?
DNA, Complementary
1
2002
273
0.040
 Why?
Point Mutation
1
2002
239
0.040
 Why?
Endometrium
1
2002
63
0.040
 Why?
Thallium Radioisotopes
1
2001
8
0.040
 Why?
Organotechnetium Compounds
1
2001
12
0.040
 Why?
Thallium
1
2001
2
0.040
 Why?
Survival Analysis
3
2010
1371
0.040
 Why?
Carcinoma, Endometrioid
1
2002
49
0.040
 Why?
Biopsy, Needle
1
2002
185
0.040
 Why?
Magnetic Resonance Imaging
2
2010
3892
0.040
 Why?
Child
1
2021
22670
0.040
 Why?
Cross-Sectional Studies
2
2025
5886
0.040
 Why?
Plasmids
1
2002
373
0.040
 Why?
Patient Care Management
1
2001
56
0.040
 Why?
Thyroid Function Tests
2
2017
19
0.040
 Why?
Life Style
1
2023
483
0.040
 Why?
Macrophages
2
2020
1500
0.040
 Why?
MutS Homolog 2 Protein
1
2020
12
0.040
 Why?
MCF-7 Cells
1
2020
132
0.040
 Why?
Specialization
1
2001
135
0.040
 Why?
Mice, Transgenic
1
2005
2185
0.040
 Why?
Health Status
1
2006
832
0.040
 Why?
Calcitonin
1
2020
27
0.040
 Why?
Models, Animal
1
2022
393
0.040
 Why?
Pituitary Hormones
1
1999
15
0.040
 Why?
Receptors, Virus
1
2020
95
0.040
 Why?
Mice, SCID
1
2020
369
0.040
 Why?
Medicine
1
2001
125
0.040
 Why?
Antineoplastic Agents, Hormonal
1
2020
192
0.040
 Why?
Validation Studies as Topic
1
2019
23
0.040
 Why?
Risk Factors
3
2023
10857
0.040
 Why?
Singapore
1
2019
27
0.040
 Why?
Immune System
1
2020
177
0.040
 Why?
Lymphoma, T-Cell, Cutaneous
1
1999
45
0.040
 Why?
Octreotide
1
1999
23
0.040
 Why?
Drug Therapy, Combination
1
2022
1043
0.040
 Why?
Mice, Inbred NOD
1
2020
613
0.040
 Why?
Cost-Benefit Analysis
1
2022
640
0.040
 Why?
Leukocytes
1
2020
296
0.030
 Why?
Prevalence
1
2025
2855
0.030
 Why?
Luminescence
1
2018
37
0.030
 Why?
Radiation Tolerance
1
1999
103
0.030
 Why?
Pharmacogenomic Variants
1
2018
34
0.030
 Why?
Kaplan-Meier Estimate
1
2020
968
0.030
 Why?
DNA Mismatch Repair
1
2018
53
0.030
 Why?
North America
1
2018
301
0.030
 Why?
Surveys and Questionnaires
3
2020
6055
0.030
 Why?
Age Factors
3
2015
3338
0.030
 Why?
Dietary Carbohydrates
1
1998
147
0.030
 Why?
Oncogenes
1
2018
118
0.030
 Why?
Interdisciplinary Communication
1
2018
200
0.030
 Why?
Delphi Technique
1
2018
330
0.030
 Why?
Liver
1
2005
1893
0.030
 Why?
Gene Frequency
1
2018
484
0.030
 Why?
Soft Tissue Neoplasms
1
2018
128
0.030
 Why?
DNA
4
1996
1433
0.030
 Why?
Advisory Committees
1
2018
229
0.030
 Why?
Tissue Distribution
1
1997
335
0.030
 Why?
Doxorubicin
1
1999
396
0.030
 Why?
Adverse Drug Reaction Reporting Systems
1
2017
81
0.030
 Why?
Health Policy
1
2020
400
0.030
 Why?
Stroboscopy
1
2016
8
0.030
 Why?
DNA Fingerprinting
1
1996
28
0.030
 Why?
Deoxyribonuclease I
1
1996
41
0.030
 Why?
RNA
1
2002
910
0.030
 Why?
Immunomodulation
1
2016
99
0.030
 Why?
Tumor Suppressor Proteins
1
2018
320
0.030
 Why?
Antithyroid Agents
2
2006
12
0.030
 Why?
High-Throughput Nucleotide Sequencing
1
2019
530
0.030
 Why?
Surgeons
1
2020
340
0.030
 Why?
Hepatitis A Virus Cellular Receptor 2
1
2015
28
0.030
 Why?
Chromosomes, Human, Pair 4
1
1995
25
0.030
 Why?
Mutagenesis, Site-Directed
1
1996
376
0.030
 Why?
Clinical Trials as Topic
1
2020
1058
0.030
 Why?
Lymphocyte Count
1
2015
163
0.030
 Why?
Mutagenesis, Insertional
1
1994
67
0.030
 Why?
Cytotoxicity, Immunologic
1
2015
224
0.030
 Why?
Gene Expression Regulation
4
1997
2588
0.030
 Why?
Microsatellite Repeats
1
2014
156
0.030
 Why?
Adipose Tissue
1
1998
644
0.030
 Why?
Risk
2
2006
916
0.020
 Why?
Age of Onset
1
2015
554
0.020
 Why?
Head and Neck Neoplasms
1
2018
561
0.020
 Why?
Proto-Oncogene Proteins c-bcl-2
1
1995
239
0.020
 Why?
Mice, Knockout
1
2020
3114
0.020
 Why?
Genes, Neoplasm
1
2013
25
0.020
 Why?
Computational Biology
1
2018
669
0.020
 Why?
Killer Cells, Natural
1
2016
478
0.020
 Why?
Gene Deletion
1
1994
391
0.020
 Why?
Preoperative Period
1
2013
149
0.020
 Why?
Neutropenia
1
2013
154
0.020
 Why?
DNA, Single-Stranded
1
1993
117
0.020
 Why?
Case-Control Studies
2
2015
3616
0.020
 Why?
Postoperative Period
1
2013
351
0.020
 Why?
Alternative Splicing
1
1994
247
0.020
 Why?
Focal Adhesion Kinase 1
1
2012
32
0.020
 Why?
Reference Values
2
2005
798
0.020
 Why?
Genetic Markers
1
2013
333
0.020
 Why?
Dasatinib
1
2012
58
0.020
 Why?
Autophagy
1
2014
288
0.020
 Why?
Recurrence
1
2015
1134
0.020
 Why?
Repressor Proteins
1
1995
429
0.020
 Why?
Age Distribution
1
2012
402
0.020
 Why?
Sex Distribution
1
2012
386
0.020
 Why?
Saccharomyces cerevisiae Proteins
1
1995
414
0.020
 Why?
Tumor Burden
1
2012
324
0.020
 Why?
Primary Health Care
1
2001
1725
0.020
 Why?
Longevity
1
2012
177
0.020
 Why?
Universities
1
2013
443
0.020
 Why?
Interleukin-6
1
2014
775
0.020
 Why?
Obesity
1
2023
3097
0.020
 Why?
Protein Processing, Post-Translational
1
2012
469
0.020
 Why?
Cell Survival
1
2012
1100
0.020
 Why?
Menopause
1
2012
326
0.020
 Why?
Physical Examination
1
2009
243
0.020
 Why?
Calreticulin
1
2008
22
0.020
 Why?
Binding Sites
3
1996
1309
0.020
 Why?
Exons
2
2002
363
0.020
 Why?
Early Detection of Cancer
1
2013
482
0.020
 Why?
Drug Administration Schedule
1
2009
781
0.020
 Why?
Insulin
1
1998
2510
0.020
 Why?
Cytokines
1
2015
2048
0.020
 Why?
Cyclin-Dependent Kinase Inhibitor Proteins
1
2006
7
0.020
 Why?
Chromans
1
2006
24
0.020
 Why?
Radiotherapy Dosage
1
2006
288
0.010
 Why?
International Cooperation
1
2006
197
0.010
 Why?
Feasibility Studies
1
2009
1109
0.010
 Why?
Angiogenesis Inhibitors
1
2006
238
0.010
 Why?
Radiography
1
2006
852
0.010
 Why?
Inflammation
1
2014
2876
0.010
 Why?
Neoplasm, Residual
1
2003
143
0.010
 Why?
Biopsy
1
2006
1079
0.010
 Why?
Culture Techniques
1
2002
66
0.010
 Why?
Peptides
1
2008
997
0.010
 Why?
Models, Biological
1
2008
1763
0.010
 Why?
Pain
1
2006
781
0.010
 Why?
Fushi Tarazu Transcription Factors
1
1999
5
0.010
 Why?
Steroidogenic Factor 1
1
1999
13
0.010
 Why?
Gonadotropins
1
1999
42
0.010
 Why?
Postmenopause
1
2002
391
0.010
 Why?
Analysis of Variance
1
2002
1300
0.010
 Why?
DNA Primers
1
1999
505
0.010
 Why?
Follicle Stimulating Hormone
1
1999
262
0.010
 Why?
Organ Specificity
1
1998
308
0.010
 Why?
GATA2 Transcription Factor
1
1997
14
0.010
 Why?
Logistic Models
1
2002
2133
0.010
 Why?
Sequence Deletion
1
1996
190
0.010
 Why?
3T3 Cells
1
1995
156
0.010
 Why?
Muridae
1
1995
6
0.010
 Why?
Replication Protein C
1
1995
4
0.010
 Why?
Repetitive Sequences, Nucleic Acid
1
1995
117
0.010
 Why?
Hybrid Cells
1
1995
49
0.010
 Why?
Macromolecular Substances
1
1995
216
0.010
 Why?
Minor Histocompatibility Antigens
1
1995
47
0.010
 Why?
Mice, Inbred DBA
1
1994
182
0.010
 Why?
Mutagenesis
1
1995
194
0.010
 Why?
Body Weight
1
1998
969
0.010
 Why?
Cloning, Molecular
1
1994
537
0.010
 Why?
Blotting, Northern
1
1993
203
0.010
 Why?
Survival Rate
1
1998
2087
0.010
 Why?
Haplotypes
1
1995
498
0.010
 Why?
Sex Factors
1
1998
2099
0.010
 Why?
Protein Biosynthesis
1
1993
451
0.010
 Why?
Rats
1
1996
5582
0.000
 Why?
Mice, Inbred C57BL
1
1995
5972
0.000
 Why?
Haugen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (516) concept(s)
_
Co-Authors Expand Description
See all (49) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)